CN115768477A - 特异性识别cd40的抗体及其应用 - Google Patents

特异性识别cd40的抗体及其应用 Download PDF

Info

Publication number
CN115768477A
CN115768477A CN202280003336.6A CN202280003336A CN115768477A CN 115768477 A CN115768477 A CN 115768477A CN 202280003336 A CN202280003336 A CN 202280003336A CN 115768477 A CN115768477 A CN 115768477A
Authority
CN
China
Prior art keywords
amino acid
acid sequence
seq
sequence seq
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280003336.6A
Other languages
English (en)
Inventor
张超
于德彬
晏丽
李平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Staidson Beijing Biopharmaceutical Co Ltd
Original Assignee
Staidson Beijing Biopharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Staidson Beijing Biopharmaceutical Co Ltd filed Critical Staidson Beijing Biopharmaceutical Co Ltd
Publication of CN115768477A publication Critical patent/CN115768477A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Abstract

本申请涉及特异性识别CD40的抗体，及其制备方法和用途。

Description

PCT国内申请，说明书已公开。

Claims (38)

  1. PCT国内申请，权利要求书已公开。
CN202280003336.6A 2021-06-29 2022-06-23 特异性识别cd40的抗体及其应用 Pending CN115768477A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110724449 2021-06-29
CN2021107244492 2021-06-29
PCT/CN2022/100683 WO2023274007A1 (zh) 2021-06-29 2022-06-23 特异性识别cd40的抗体及其应用

Publications (1)

Publication Number Publication Date
CN115768477A true CN115768477A (zh) 2023-03-07

Family

ID=84690753

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280003336.6A Pending CN115768477A (zh) 2021-06-29 2022-06-23 特异性识别cd40的抗体及其应用

Country Status (2)

Country Link
CN (1) CN115768477A (zh)
WO (1) WO2023274007A1 (zh)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3178851T (pt) * 2010-03-31 2020-07-17 Boehringer Ingelheim Int Anticorpos anti-cd40
ES2733646T3 (es) * 2011-03-11 2019-12-02 Beth Israel Deaconess Medical Ct Inc Anticuerpos anti-CD40 y usos de los mismos
WO2012149356A2 (en) * 2011-04-29 2012-11-01 Apexigen, Inc. Anti-cd40 antibodies and methods of use
EP3303395B1 (en) * 2015-05-29 2019-12-11 AbbVie Inc. Anti-cd40 antibodies and uses thereof
CN116063481A (zh) * 2015-09-04 2023-05-05 普里玛托普医疗股份有限公司 人源化抗-cd40抗体及其用途
KR102198998B1 (ko) * 2017-06-01 2021-01-07 서울대학교 산학협력단 신규한 항-ｃｄ40 항체 및 이의 용도
AR117091A1 (es) * 2018-11-19 2021-07-07 Bristol Myers Squibb Co Anticuerpos monoclonales antagonistas contra cd40 y sus usos
WO2020154335A1 (en) * 2019-01-22 2020-07-30 Revmab Biosciences Usa, Inc. Novel anti-cd40 antibodies

Also Published As

Publication number Publication date
WO2023274007A1 (zh) 2023-01-05

Similar Documents

Publication Publication Date Title
CN114555639B (zh) 特异性识别白细胞介素-4受体α的抗体及其用途
JP2023011887A (ja) 顆粒球－マクロファージコロニー刺激因子受容体αを特異的に認識する抗体及びその使用
CN114364695A (zh) 特异性识别c5a的抗体及其应用
WO2023274007A1 (zh) 特异性识别cd40的抗体及其应用
WO2023284714A1 (zh) 特异性识别cd40的抗体及其应用
WO2023030501A1 (zh) 特异性识别FcRn的抗体及其应用
WO2024067344A1 (zh) 特异性识别light的抗体及其应用
WO2023016538A1 (en) Antibodies specifically recognizing fcrn and uses thereof
WO2023138521A1 (zh) 特异性识别FasL的抗体及其应用
WO2023066171A1 (zh) 特异性结合乙型肝炎病毒表面抗原pre-S1的抗体及其应用
WO2023217068A1 (zh) 特异性识别gdf15的抗体及其应用
WO2024056010A1 (zh) 特异性识别nkg2a的抗体及其应用
WO2023186054A1 (zh) 特异性识别c5a的抗体及其应用
WO2024083021A1 (zh) 特异性结合TRAIL或FasL的抗体组合以及双特异性抗体
WO2022166739A1 (en) Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereof
CN116829594A (zh) 特异性识别FasL的抗体及其应用
CN117917436A (zh) 特异性识别trail的抗体及其应用
CN117917437A (zh) 特异性识别trail的抗体及其应用
TW202317633A (zh) 特異性識別ｔｎｆｒ２的抗體及其用途
WO2024020407A1 (en) Antibodies specifically recognizing b- and t-lymphocyte attenuator (btla) and uses thereof
WO2024040212A2 (en) Antibodies specifically recognizing programmed cell death 1 ligand 1 and uses thereof
CN115925918A (zh) 特异性识别c5a的抗体及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination